Works matching IS 1742464X AND DT 2021 AND VI 288 AND IP 17
Results: 17
Spotlight on COVID‐19: eighteen months on.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 4992, doi. 10.1111/febs.16167
- By:
- Publication type:
- Article
Protons to Patients: targeting endosomal Na<sup>+</sup>/H<sup>+</sup> exchangers against COVID‐19 and other viral diseases.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5071, doi. 10.1111/febs.16163
- Publication type:
- Article
Identification of a special cell type as a determinant of the kidney tropism of SARS‐CoV‐2.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5163, doi. 10.1111/febs.16114
- By:
- Publication type:
- Article
The role of T‐cell immunity in COVID‐19 severity amongst people living with type II diabetes.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5042, doi. 10.1111/febs.16105
- By:
- Publication type:
- Article
Targeting neuropilins as a viable SARS‐CoV‐2 treatment.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5122, doi. 10.1111/febs.16096
- By:
- Publication type:
- Article
COVID‐19 vaccines: what do we know so far?
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 4996, doi. 10.1111/febs.16094
- By:
- Publication type:
- Article
Infection‐induced inflammation from specific inborn errors of immunity to COVID‐19.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5021, doi. 10.1111/febs.15961
- By:
- Publication type:
- Article
Host PDZ‐containing proteins targeted by SARS‐CoV‐2.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5148, doi. 10.1111/febs.15881
- By:
- Publication type:
- Article
Non‐optimal codon usage preferences of coronaviruses determine their promiscuity for infecting multiple hosts.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5201, doi. 10.1111/febs.15835
- By:
- Publication type:
- Article
New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'‐5' exoribonucleolytic activity on SARS‐CoV‐2.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5130, doi. 10.1111/febs.15815
- By:
- Publication type:
- Article
The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5179, doi. 10.1111/febs.15784
- By:
- Publication type:
- Article
Overview of antiviral drug candidates targeting coronaviral 3C‐like main proteases.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5089, doi. 10.1111/febs.15696
- By:
- Publication type:
- Article
The structural basis of accelerated host cell entry by SARS‐CoV‐2†.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5010, doi. 10.1111/febs.15651
- By:
- Publication type:
- Article
The effects of aging on host resistance and disease tolerance to SARS‐CoV‐2 infection.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5055, doi. 10.1111/febs.15613
- By:
- Publication type:
- Article
Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID‐19 patients.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5190, doi. 10.1111/febs.15609
- By:
- Publication type:
- Article
Table of Contents.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5224, doi. 10.1111/febs.15409
- Publication type:
- Article
Issue Information.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 4989, doi. 10.1111/febs.15408
- Publication type:
- Article